Deferoxamine

Deferoxamine （订货以CAS编码或英文名称为准）

Deferoxamine (Deferoxamine B) 是一种铁螯合剂 (结合 Fe(III) 和许多其他金属阳离子)，被广泛用于减少铁在组织中的积累和沉积。Deferoxamine 具有较好的抗氧化活性，可上调 HIF-1α 水平。Deferoxamine 还具有抗增殖活性，能诱导癌细胞凋亡和自噬。Deferoxamine 可用于糖尿病、神经退行性疾病以及抗癌和抗 COVID-19 的研究。

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PL05539

分子式：C25H48N6O8

CAS号：70-51-9

分子量：560.68

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PL05539-5mg	Medlife	5mg	≥98%	¥9520.00	登录后可见
PL05539-10mg	Medlife	10mg	≥98%	¥15454.55	登录后可见
PL05539-50mg	Medlife	50mg	≥98%	待询	登录后可见
PL05539-100mg	Medlife	100mg	≥98%	待询	登录后可见

中文名称：	去铁胺
中文别名：	去铁胺;去铁敏;3-癸酮
英文名称：	Deferoxamine
英文别名：	N1-(5-Aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide;desferrioxamine;Deferoxamine;N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;N1-(5-Aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)-pentyl)amino)-4-oxobutanamido)pentyl)succinam...;Deferoxamin;Deferoxamine B;Deferoxaminum;Deferrioxamine;Deferrioxamine B;Desferal;Desferin;Desferrioxamine B;desferrioxamine mesylate;N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide;Deferoxamine B; Deferriferrioxamine B; Deferrioxamine;N~1~-(5-(Acetyl(hydroxy)amino)pentyl)-N~4~-(5-((4-((5-aminopentyl)(hydroxy)amino)-4-oxobutanoyl)amino)pentyl)-N~4~-hydroxysuccinamide;KBio2_004997;AB00053447;NCGC00178802-02;NSC527604;C25H48N6O8;UNII-J06Y7MXW4D;N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N''''-(5-aminopentyl)-N''''-hydroxybutanediamide;methanesulfonic acid;NSC268993;NCGC00178802-01;desferrioxamine-B;DTXSID7022887;Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-;D03670;N-[5-(3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido)pentyl]-3-([5-(N-hydroxyacetamido)pentyl]carbamoyl)propionohydroxamic acid;Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-;DEFEROXAMINE [INN];3,14,20,25-Pentaazatriacontane-2,10,13,21,24-pentone, 30-amino-3,14,25-trihydroxy-;Ba 29837 (Salt/Mix);deferoxamine-mesylate;SBI-0051332.P003;Desferoxamine b;AKOS016004824;HY-B1625;CHEBI:4356;Desferal (Salt/Mix);CS-0013559;BRD-K09821361-066-08-4;Desferex;SCHEMBL34571;Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-;Deferoxamide B;DF B;Ferrioxamine B, N-benzoyl-;C06940;BCP16524;Ba 33112;Prestwick2_000725;Desferriferrioxamin B;LS-124964;70-51-9;30-Amino-3,14,25-trihydroxy-3,9,14,20,25-pentaazatriacontane-2,10,13,21,24-pentaone;F11488;DEFEROXAMINE [HSDB];BDBM47715;KBio2_006508;EINECS 200-738-5;1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(N-acetyl hydroxylamino)-6,11,17,22-tetraazaheptaeicosane;N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid;Cordaneurin;AB00053447_14;Q-200933;Spectrum4_000311;DFOM;HSDB 3311;BSPBio_000650;BRD-K09821361-066-15-9;CGH-749B;SMR000058548;Deferoxamina [INN-Spanish];Desferan;KBioGR_002429;J06Y7MXW4D;Dfo-b;DEFEROXAMINE [USAN];2C10H20N2O3.C5H13N.C3H7NO2;N'-{5-[acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxybutanediamide;NSC-527604;N-[5-[[4-[5-[acetyl(hydroxy)amino]penty...
CAS号：	70-51-9
分子式：	C25H48N6O8
分子量：	560.68
详细描述	Deferoxamine (Deferoxamine B) 是一种铁螯合剂 (结合 Fe(III) 和许多其他金属阳离子)，被广泛用于减少铁在组织中的积累和沉积。Deferoxamine 具有较好的抗氧化活性，可上调 HIF-1α 水平。Deferoxamine 还具有抗增殖活性，能诱导癌细胞凋亡和自噬。Deferoxamine 可用于糖尿病、神经退行性疾病以及抗癌和抗 COVID-19 的研究。

搜索质检报告(COA)